Skip to main content

H.R. 2477

Referred to Committee

Beneficiary Enrollment Notification and Eligibility Simplification Act of 2020

Introduced 5/2/2019•116th Congress•House

Latest Action

Received in the Senate and Read twice and referred to the Committee on Finance.

12/9/2020 • Senate

Summary

Beneficiary Enrollment Notification and Eligibility Simplification Act of 2020 or the BENES Act of 2020

This bill modifies requirements relating to Medicare enrollment, coverage of immunosuppressive drugs for kidney transplant recipients, secondary payer reporting, and hospice survey requirements.

Among other provisions, the bill

  • generally requires Medicare coverage to begin on the first day of the month following enrollment for individuals who enroll in the latter months of their initial enrollment period;
  • requires Social Security account statements for individuals attaining ages 63 to 65 to include information about Medicare eligibility, late enrollment penalties, and other information;
  • indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage;
  • requires the Centers for Medicare & Medicaid Services to share Medicare Advantage and Medicare prescription drug benefit enrollment information with liability insurers in response to Medicare secondary payer inquiries; and
  • establishes survey requirements for, and enforcement mechanisms against, certified hospice programs under Medicare.

Passed House • 12/8/2020

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Administrative remediesCongressional oversightDepartment of Health and Human ServicesDigestive and metabolic diseasesGovernment information and archivesGovernment studies and investigationsHealth care coverage and accessHealth care qualityHealth facilities and institutionsImmunology and vaccinationLong-term, rehabilitative, and terminal careMedicareOrgan and tissue donation and transplantationPrescription drugsSocial Security Administration

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (19)

Party Breakdown

12
Democrats
7
Republicans
0
Independents

Sponsor

R[
Rep. Ruiz, Raul [D-CA-36]

Democrat • CA-36

Sponsored 5/2/2019

Cosponsors (18)

R[
Rep. Walorski, Jackie [R-IN-2]

R-IN-2

Joined 5/2/2019

R[
Rep. Bilirakis, Gus M. [R-FL-12]

R-FL-12

Joined 5/2/2019

R[
Rep. Tipton, Scott R. [R-CO-3]

R-CO-3

Joined 9/11/2019

R[
Rep. Posey, Bill [R-FL-8]

R-FL-8

Joined 10/16/2019

R[
Rep. Sewell, Terri A. [D-AL-7]

D-AL-7

Joined 10/16/2019

Bill Journey

Originated in the House

Introduced

May 2, 2019

Committee Review

January 8, 2020

Subcommittee Hearings Held.

Floor Debate

December 8, 2020

Passed Chamber

December 8, 2020

Other Chamber

President

Enacted into Law

Text Versions (3)

Referred in Senate12/9/2020
Engrossed in House12/8/2020
Introduced in House5/2/2019

Committee Reports (1)

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors18